Ex vivo expansion does not alter the capacity of umbilical cord blood CD34+ cells to generate functional T lymphocytes and dendritic cells

Stem Cells

Volumn 24, Issue 9, 2006, Pages 2150-2157

  Kobari, Ladan ^a   Giarratana, Marie C ^a   Gluckman, Jean C ^b   Douay, Luc ^a,c,e   Rosenzwajg, Michelle ^a,d  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d CNRS   (France)

^e ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Cord blood; Dendritic cell differentiation; Ex vivo expansion; Hematopoietic progenitor cells; Immune competence; Lymphopoiesis; T cell repertoire

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; T LYMPHOCYTE RECEPTOR; T6 ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL ISOLATION; DENDRITIC CELL; EX VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD34; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FETAL BLOOD; HUMANS; INTERFERON TYPE II; MICE; MICE, INBRED NOD; MICE, SCID; ORGAN CULTURE TECHNIQUES; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 33749178918     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0102     Document Type: Article

References (39)

1. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-1577.
2. Madrigal JA, Cohen SB, Gluckman E et al. Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango. Hum Immunol 1997;56:1-5.
3. - population. Blood 1999;93:2302-2307.
4. Cohen SB, Madrigal JA. Immunological and functional differences between cord and peripheral blood. Bone Marrow Transplant 1998;21(suppl 3):S9-12.
5. - dendritic cell subsets in cord blood. Br J Haematol 2001;113:925-931.
6. + cells. Blood 1993;82:3600-3609.
7. Petzer AL, Hogge DE, Landsdorp PM et al. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci U S A 1996;93:1470-1474.
8. Kobari L, Pflumio F, Giarratana M et al. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells. Exp Hematol 2000;28:1470-1480.
9. + cells into rapid division. Exp Hematol 1999;27:1019-1028.
10. - cells with preserved ability to engraft SCID-hu bone. Blood 1998;91:1206-1215.
11. Conneally E, Cashman J, Petzer A et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A 1997;94:9836-9841.
12. Piacibello W, Sanavio F, Severino A et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999;93:3736-3749.
13. Caux C, Dezutter-Dambuyant C, Schmitt D et al. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-261.
14. + hematopoietic precursor cells. Blood 1996;87:535-544.
15. + progenitor cells. Exp Hematol 1998;26:63-72.
16. + subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures. Br J Haematol 1999;104:809-819.
17. Giarratana MC, Verge V, Schmitt C et al. Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures. Exp Hematol 2000;28:46-54.
18. Douay L, Giarratana MC, Drouet X et al. The role of recombinant haematopoietic growth factors in human long-term bone marrow culture in serum-free medium. Br J Haematol 1991;79:27-32.
19. Giarratana MC, Kobari L, Neildez Nguyen TM et al. Cell culture bags allow a large extent of ex vivo expansion of LTC-IC and functional mature cells which can subsequently be frozen: Interest for a large-scale clinical applications. Bone Marrow Transplant 1998;22:707-715.
20. Kerre TC, De Smet G, De Smedt M et al. Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34(+) cells. Blood 2002;99:1620-1626.
21. Kobari L, Giarratana MC, Poloni A et al. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6. Bone Marrow Transplant 1998;21:759-767.
22. + progenitors in human bone marrow. J Immunol 1992;149:2681-2688.
23. McCune JM, Namikawa R, Kaneshima H et al. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241:1632-1639.
24. + fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment. Blood 1994;84:1587-1593.
25. - subset. J Immunol 1991;146:4078-4084.
26. Robin C, Pflumio F, Vainchenker W et al. Identification of lymphomyeloid primitive progenitor cells in fresh human cord blood and in the marrow of nonobese diabetic-severe combined immunodeficient (NODSCID) mice transplanted with human CD34(+) cord blood cells. J Exp Med 1999;189:1601-1610.
27. Tanaka T, Kitamura F, Nagasaka Y et al. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med 1993;178:1103-1107.
28. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
29. Chen W, Antonenko S, Sederstrom JM et al. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004;103:2547-2553.
30. Res P, Blom B, Hori T et al. Downregulation of CD1 marks acquisition of functional maturation of human thymocytes and defines a control point in late stages of human T cell development. J Exp Med 1997;185:141-151.
31. + single-positive T cells in murine fetal thymus organ culture. Proc Natl Acad Sci U S A 1993;90:10778-10782.
32. + cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 2002;169:204-209.
33. + cells using the NOD/SCID/gammacnull mice model. Blood 2003;102:873-880.
34. Ferrara JL. Pathogenesis of acute graft-versus-host disease: Cytokines and cellular effectors. J Hematother Stem Cell Res 2000;9:299-306.
35. Shlomchik WD, Couzens MS, Tang CB et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999;285:412-415.
36. Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-376.
37. Arrighi JF, Hauser C, Chapuis B et al. Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor. Blood 1999;93:2244-2252.
38. Urbini B, Arpinati M, Bonifazi F et al. Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant. Exp Hematol 2003;31:959-965.
39. Cohena Y, Nagler A. Hematopoietic stem-cell transplantation using umbilical-cord blood. Leuk Lymphoma 2003;44:1287-1299.